Prog Med Phys.  2015 Sep;26(3):185-191. 10.14316/pmp.2015.26.3.185.

The Results of the Survey about Present Situation of Quality Assurance for Radiotherapy Machine of Korea

• Jeong S
• Yoon M
• Lee H

• KMID: 2069482
• DOI: http://doi.org/10.14316/pmp.2015.26.3.185

Abstract

As radiation therapy is one of three major cancer treatment methods, many cancer patients get radiation therapy. Because of the invisible and scattering characteristics of radiation, it is impossible to identify the quality and the amount of radiation and secondary cancer could be induced by scattered radiation. Because of advanced technique of radiation therapy and the reasons mentioned above, quality assurance of radiotherapy machine should be performed completely. International organizations such as International Atomic Energy Agency (IAEA), American Association of Physicists in Medicine (AAPM) suggest report of quality assurance to recommend united method of radiotherapy machine quality assurance. Domestic society of medical physics, however, is too small to make such a report, domestic hospitals selectively choose some of contents in global suggestions. As there are no suggestions for domestic hospitals and global suggestions are being updated, we did a survey about quality assurance for radiotherapy machine. The questionnaire is composed of possession of radiotherapy machine, items performed for quality assurance and manpower, etc. 37 of 72 hospitals answered to survey. These results could be used for making domestic standard quality assurance procedure.

Keyword

Radiation therapy; Quality assurance; Domestic situation; Procedure of quality assurance

MeSH Terms

Humans
Korea*
Nuclear Energy
Radiotherapy*

Figure

• 

  Fig. 1. Manpower rate of quality assurance classified by academic level (a), major (b).

Reference

References

1. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. International Journal of Radiation Oncology Biology Physics. 56(1):83–88. 2003.

2. Kim S, Min BJ, Yoon M, et al. Secondary radiation doses of intensitymodulated radiotherapy and proton beam therapy in patients with lung and liver cancer. Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 98(3):335–339. 2011.

3. AAPM TG No. 35: Medical Accelerator Safety considerations. American Association of Physicist in Medicine (. 1993.

4. IAEA-TECDOC-989: Quality Assurance in Radiotherapy. International Atomic Energy Agency, Vienna (. 1997.

5. AAPM TG No. 142: Quality assurance of medical acce lerators. American Association of Physicist in Medicine (. 2009.

6. ECRP Radiation Protection No. 149: Medical Overexposures. European Commission Radiation Protection (. 2003.

7. Lee SH, Kim JR, Cho SJ, et al. Analysis and Investigation for the Status of Radiation Therapy QA in Korea. Korean Journal of Medical Physics. 21(2):223–231. 2010.

8. AAPM TG No. 41: Remote afterloading technology. American Association of Physicists in Medicine (. 1993.

9. AAPM TG No. 43: Dosimetry of interstitial Brachytherapy Source. American Association of Physicists in Medicine (. 1995.

10. AAPM TG No. 56: Code of particle for for brachytherapy physics. American Association of Physicists in medicine (. 1997.

11. AAPM TG No. 40: Comprehensive QA for Radiation Oncology. American Association of Physicist in Medicine (. 1994.